Talphera, Inc. (TLPH)
0.739
-0.06
(-7.62%)
USD |
NASDAQ |
Nov 19, 16:00
0.7326
-0.01
(-0.87%)
After-Hours: 20:00
Talphera Price to Book Value : 3.584 for Nov. 19, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 19, 2026 | 3.584 |
| November 18, 2026 | 3.880 |
| November 17, 2026 | 3.883 |
| November 16, 2026 | 4.175 |
| November 13, 2026 | 4.394 |
| November 12, 2026 | 5.019 |
| November 11, 2026 | 5.092 |
| November 10, 2026 | 5.092 |
| November 09, 2026 | 5.286 |
| November 06, 2026 | 5.092 |
| November 05, 2026 | 4.898 |
| November 04, 2026 | 5.092 |
| November 03, 2026 | 5.043 |
| November 02, 2026 | 4.898 |
| October 30, 2026 | 4.995 |
| October 29, 2026 | 5.189 |
| October 28, 2026 | 5.286 |
| October 27, 2026 | 5.286 |
| October 26, 2026 | 5.189 |
| October 23, 2026 | 5.237 |
| October 22, 2026 | 5.092 |
| October 21, 2026 | 5.189 |
| October 20, 2026 | 5.189 |
| October 19, 2026 | 5.237 |
| October 16, 2026 | 5.237 |
| Date | Value |
|---|---|
| October 15, 2026 | 5.189 |
| October 14, 2026 | 5.140 |
| October 13, 2026 | 5.189 |
| October 12, 2026 | 5.237 |
| October 09, 2026 | 5.237 |
| October 08, 2026 | 5.237 |
| October 07, 2026 | 5.092 |
| October 06, 2026 | 5.383 |
| October 05, 2026 | 5.625 |
| October 02, 2026 | 5.480 |
| October 01, 2026 | 5.431 |
| September 30, 2026 | 5.625 |
| September 29, 2026 | 4.216 |
| September 28, 2026 | 4.288 |
| September 25, 2026 | 4.252 |
| September 24, 2026 | 4.216 |
| September 23, 2026 | 4.180 |
| September 22, 2026 | 4.216 |
| September 21, 2026 | 4.216 |
| September 18, 2026 | 4.180 |
| September 17, 2026 | 4.216 |
| September 16, 2026 | 4.288 |
| September 15, 2026 | 4.288 |
| September 14, 2026 | 4.468 |
| September 11, 2026 | 4.468 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Relmada Therapeutics, Inc. | 1.713 |
| Journey Medical Corp. | 3.107 |
| ANI Pharmaceuticals, Inc. | 2.485 |
| Corcept Therapeutics, Inc. | 8.524 |
| Veru, Inc. | 1.268 |
Price to Book Value Related Metrics
| Price | 0.739 |
| Earnings Yield | -27.50% |
| Market Cap | 38.39M |